| Line 54: |
Line 54: |
| | | | |
| | | | |
| − | === Perfusion Day === | + | === Perfusion Day (2026-10-31) === |
| | | | |
| − | Rats injected with one of the following solutions (staggered in pairs by 15-20min): | + | Rats (n=9, d.o.ob 2026-7-2, arr. 2026-9-1) injected with one of the following solutions (staggered in pairs by 15-20min): |
| | | | |
| | * 75 mM LiOr/Tris, 6 ml/kg ip. (SRA01, SRA04, SRA07) | | * 75 mM LiOr/Tris, 6 ml/kg ip. (SRA01, SRA04, SRA07) |
| Line 64: |
Line 64: |
| | These are same doses used in [[SNB Lithium Orotate CTA 2]], which showed that LiOr had greater potency in CTA conditioning than LiCl. | | These are same doses used in [[SNB Lithium Orotate CTA 2]], which showed that LiOr had greater potency in CTA conditioning than LiCl. |
| | | | |
| − | One hour after injection, rats are overdosed with sodium pentobarbital and transcardially perfused. Brains are dissected, and placed into 0.1M PB for storage, then transferred to 30% sucrose overnight before sectioning. | + | One hour after injection, rats are overdosed with sodium pentobarbital and transcardially perfused. Brains were dissected, postfixed for ~1 h, then transferred to 30% sucrose before sectioning. |
| | | | |
| − | * 0: inject SRA01,SRA02 | + | * 0: inject SRA01,SRA02 (1015) |
| | * 20: inject SRA03, SRA04 | | * 20: inject SRA03, SRA04 |
| | * 40: inject SRA05, SRA06 | | * 40: inject SRA05, SRA06 |
| Line 74: |
Line 74: |
| | * 120: perfuse SRA07, SRA08 | | * 120: perfuse SRA07, SRA08 |
| | * 140: perfuse SRA09 | | * 140: perfuse SRA09 |
| | + | |
| | + | 30% sucrose (1500) |
| | | | |
| | === c-Fos Immunohistochemistry === | | === c-Fos Immunohistochemistry === |